MetroHealth is nationally recognized for medical and psychiatric research.  From laboratory to patient clinics, the staff believes in the resarch conducted at the hospital and hopes that discovery of new drugs may help to alleviate some of the ills that are experienced by mental health consumers.  Excellence in research is fundamental in the ability to deliver outstanding care.

Staff members are invited to participate in both government research as well as industry sponsored trials.  The Department fosters development of investigator initiated trials. Publishing is strongly encouraged and the faculty members are readily available for mentoring growth as a researcher.  The research office provides full time support and liaison services with the Institutional Review Board and the Research Grants Office.

The Clinical Trials Unit in the Department of Psychiatry offers opportunities for the investigation of new pharmaceutical products and development of new tools for psychometric measurement.  Clinical trials experience includes:

• Alcohol and substance addiction behaviors
• Anxiety disorders
• Biploar disorders
• Down syndrome
• Erectile dysfunction
• Female arousal disorders
• Female hypoactive sexual disorders
• Major depressive disorder
• Mental retardation
• Panic disorder
• Premenstrual dysphoric disorder
• Schizophrenia
• Smoking cessation

MetroHealth Department of Psychiatry has partnered with the following and served as clinical trial site for:

• Abbott Laboratories 
• AstraZeneca 
• Berlex 
• Boehringer Ingelheim 
• BristolMyersSquibb 
• Eli Lilly 
• Forrest
• Glaxo Wellcome, GlaxoSmithKline 
• ICON 
• Janssen 
• Novartis 
• Organon 
• Otsuka 
• Pentech 
• Pfizer 
• Sepracor
• Takeda 
• United Biosource Corporation 
• Upjohn 
• Wyeth
• Zestra

Research projects are under the leadership of Ewald Horwath, MD, and Terry Stancin, PhD.